FibroGen Announces Sale of China Subsidiary to AstraZeneca for Approximately $160 Million
来源:
NASDAQ Stocks
/
20 2月 2025 07:51:49 America/New_York
FibroGen sells its China subsidiary to AstraZeneca for $160 million, extending cash runway and advancing oncology pipeline. https://www.nasdaq.com/articles/fibrogen-announces-sale-china-subsidiary-astrazeneca-approximately-160-million
分享